Regulus Therapeutics CEO Joseph Hagan's 2020 pay rises 16% to $2.3M
Regulus Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 30, 2021
Regulus Therapeutics reported fiscal year 2020 executive compensation information on April 30, 2021.
In 2020, three executives at Regulus Therapeutics received on average a compensation package of $1.3M, a 50% increase compared to previous year.
Average pay of disclosed executives at Regulus Therapeutics
Joseph P. Hagan, Chief Executive Officer, received $2.3M in total, which increased by 16% compared to 2019. 65% of Hagan's compensation, or $1.5M, was in option awards. Hagan also received $265K in non-equity incentive plan, $552K in salary, as well as $9.9K in other compensation.
Christopher R. Aker, General Counsel, received a compensation package of $809K, which increased by 3% compared to previous year. 43% of the compensation package, or $352K, was in option awards.
Cris Calsada, Chief Financial Officer, earned $708K in 2020, a 134% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 30, 2021.